This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Rochester Medical Corporation F3Q10 (Qtr End 06/30/10) Earnings Call Transcript

Rochester Medical Corporation (ROCM)

F3Q10 (Qtr End 06/30/10) Earnings Call Transcript

July 29, 2010 4:30 pm ET


Anthony Conway – Chairman, CEO and President

David Jonas – CFO, Treasurer and Secretary


Tyson Bauer – Wealth Monitors Incorporated

Beth Lilly – Gabelli

Michael Boulgaris – Boulgaris Investments



Good day, ladies and gentlemen, and welcome to the third quarter 2010 Rochester Medical Corporation earnings call. At this time, all participants are in listen-only mode. (Operator instructions) We will accept your questions at the end of this conference. As a reminder, today's call is being recorded.

I would now turn the call over to Mr. Anthony J. Conway, President and CEO. Please proceed.

Anthony Conway

Thank you for joining our third quarter conference call today. I am Anthony Conway, the company's President and CEO, and with me is David Jonas, Rochester Medical's Chief Financial Officer.

To start, I will review the highlights of the quarter and then David will present detailed information on the financials and what they signify. And after that, we will be happy to take your questions.

As always, before starting, let me remind you that we will be making some forward-looking statements today. And I would refer you to the Safe Harbor statement found in today’s press release and also to the Risk Factors section in the company's Annual Report on Form 10-K for the year ended September 30th, 2009. These statements further clarify the risks and uncertainties that are associated with the forward-looking statements.

All right. First, let me review the results as reported in the press release. We reported record sales of $10,244,000 for the current quarter compared to $8,908,000 for the third quarter of last year. That's approximately a 17% increase in overall sales on a constant currency basis.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $117.81 0.00%
FB $105.45 0.00%
GOOG $750.26 0.00%
TSLA $231.61 0.00%
YHOO $32.94 0.00%


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs